Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Patent
1995-05-18
1996-08-27
Shippen, Michael L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
562440, A61K 31195
Patent
active
055501591
ABSTRACT:
This invention relates to compounds having the following formula ##STR1## or pharmaceutically acceptable salt thereof which are useful in the inhibition of platelet aggregation, to pharmaceutical compositions of such phenylamidines derivatives, and to a method of inhibiting platelet aggregation in mammals by administering such compounds and compositions.
REFERENCES:
patent: 5053392 (1991-10-01), Klein et al.
patent: 5239113 (1993-08-01), Bovy, et al.
patent: 5272162 (1993-12-01), Tjoeng et al.
patent: 5273982 (1993-12-01), Alig et al.
patent: 5314902 (1994-05-01), Tjoeng et al.
patent: 5344957 (1994-09-01), Bovy et al.
patent: 5354738 (1994-10-01), Tjoeng et al.
U.S. application Ser. No. 07/777,811, filed Oct. 15, 1991, Bovy.
R. Ferroni, et al. "Ethyl esters of N-amidinobenzoyl amino acids: inhibitory effects on thrombin, blood coagulation, and platelet aggregation", Chemical Abstracts, vol. 108, p. 17, No. 48724q, (1988).
T. Yokoyama, et al. "New synthetic inhibitors of chymotrypsin, trypsin, thrombin, plasmin, urokinase, tissue plasminogen activator, factor Xa, tissue kallikrein, and plasma kallikrein", Chemical Abstracts, vol. 107, p. 361, No. 193882y, (1987).
J. Stuerzebecher, et al. "Synthetic inhibitors of serine proteinases. Part 32: Inhibition of trypsin, plasmin, and thrombin by amides of N-alpha-substituted-4-amidinophenylalanine. Influence of various amino acids and blocking groups of the N-alpha-residue on the inhibitory activity", Chemical Abstracts, vol. 107, p. 327, No. 92532d, (1987).
B. Voigt, et al. "Synthesis of N-alpha-benzyloxycarbonyl-4-amidino-phenylalanine amides as thrombin inhibitors", Chemical Abstracts, vol. 104, p. 603, No. 186094c, (1986).
J. Stuerzebecher, et al. "Synthetic inhibitors of serine proteinases. 13. Quantitative structure-activity relations for inhibition of trypsin, plasmin, and thrombin by 4-amidinophenyl compounds with a keto group", Chemical Abstracts, vol. 87, p. 19, No. 62379k, (1977).
U.S. application Ser. No. 08/138,559, filed Oct. 15, 1993, Bovy, et al.
U.S. application Ser. No. 08/019,923, filed Feb. 19, 1993, Tjoeng, et al.
Hartman, et al. "Non-peptide Fibrinogen Receptor Antagonists. 1. Discovery and Design of Exosite Inhibitors", J. Med. Chem., vol. 35, pp. 4640-4642 (1992).
Bovy Philippe R.
Garland Robert B.
Miyano Masateru
Rico Joseph G.
Rogers Thomas E.
G. D. Searle & Co.
Kovacevic Cynthia S.
Shippen Michael L.
Williams Roger A.
LandOfFree
Peptide mimics useful as platelet aggregation inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Peptide mimics useful as platelet aggregation inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptide mimics useful as platelet aggregation inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1056522